Abstract
AbstractAdult female rats were injected with 15 μg β‐endorphin twice, at 12: 00 and 15: 00, on the day of proestrus, with or without pretreatment with the antiserotonergic drug p‐chlorophenylalanine (PCPA, 300 mg/kg) or the anticholinergic drug atropine sulfate (150mg/kg). Administration of β‐endorphin alone caused a slight decrease in pre‐ovulatory LH release and blocked ovulation in 4 of the 10 animals. Pretreatment with PCPA, but not atropine, completely blocked the β‐endorphin action. Injection with naloxone (2 mg/kg) induced a significant increase in serum LH levels 60 minutes later in immature female rats. The naloxone‐induced LH rise was reduced by concomitant intraperitoneal administration of β‐endorphin (200 μg/kg). This β‐endorphin inhibition of naloxone action was, however, completely abolished by pretreatment with PCPA, while PCPA showed a tendency to potentiate the LH response to naloxone alone. These results suggest that serotonergic systems participate in the mechanisms whereby β‐endorphin suppresses LH secretion. In addition, the stimulatory action of naloxone on LH secretion was markedly suppressed when reserpine (2 mg/kg) or phenoxybenzamine (20 mg/kg), all antinoradrenergic drugs, were first administered, suggesting that the naloxone action to promote LH release is mediated in part via hypothalamic noradrenergic systems.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Asia-Oceania journal of obstetrics and gynaecology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.